CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 127 enrolled
Drug / intervention
Transabdominal Plane Block +1 moredrug
Likely dose
Transabdominal Plane Block 50mlfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02007096
NCT02007096Phase 2Completed
CompareCT.gov

Transabdominal Plane (TAP) Blocks in Ventral Hernia Repair

Icahn School of Medicine at Mount Sinai·interventional·Posted Dec 10, 2013·Updated Jan 19, 2018

In Brief

A Phase 2 clinical trial evaluating Transabdominal Plane Block and Non Transabdominal Plane Block for Ventral Hernia and 4 related conditions. Completed, enrolled 127 participants across 1 site.

Detailed Summary

The purpose of this study is to determine if a Transabdominal Plane Block will decrease patient pain and pain medication use after a laparoscopic ventral (ventral, umbilical, incisional) hernia repair with mesh.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVentral Hernia, Umbilical Hernia, Incisional Hernia, Postoperative Complications, Pain, Postoperative
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedDec 10, 2013
Enrollment StartAug 1, 2012
Primary CompletionOct 1, 2014
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 12.6 years ago

Interventions

Transabdominal Plane Blockdrug

0.25% bupivacaine injection in 6 different locations in abdomen. Weight \<100kg: 50ml total; weight \>100kg: 60ml total

Non Transabdominal Plane Blockdrug

Saline injection in 6 different locations in abdomen. Weight \<100kg: 50ml; weight \>100kg: 60ml